Results 51 to 60 of about 242,136 (99)

Comprehensive Bioinformatic Analysis of TONSL Expression in Pan-Cancer. [PDF]

Cancer Rep (Hoboken)
Yang Y, Zhou B.
europepmc   +1 more source

A pan-cancer analysis of TMEM132A in human tumors. [PDF]

Discov Oncol
Chu T, Lei C, Zhang X, Wang Y, Gao M.
europepmc   +1 more source

Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A). [PDF]

J Mol Med (Berl)
Rice K, Lehtinen N, Välimäki E, Suhonen J, Taimen P, Kettunen K, Ventelä S, Kononen J, Sihto H, Rantala JK.   +9 more
europepmc   +1 more source

Decoding the Oncogenic Role of USP22 Through Pan-Cancer Genomic and Epigenetic Analysis. [PDF]

Cancer Rep (Hoboken)
A UD, Shukla PK.
europepmc   +1 more source

Pan-cancer 8q24 amplification predicts primary immunotherapy resistance and therapeutic vulnerabilities. [PDF]

iScience
Chen C, Liu S, Feng J, Luo Z, Bi Y, Huang Q, Zhang Y, Yu H, Wu J, Yu H, Liu R, Hu J, Ye L, Zhu Y, He Y, Chen L, Lu L, Gong K.   +17 more
europepmc   +1 more source

Comprehensive pan-cancer analysis of FSCN1 as a marker for prognosis and immunity. [PDF]

Discov Oncol
Xu R, Xu W, Dong C, Qiang G.
europepmc   +1 more source

Pan-cancer analysis identifies JMJD6 as an oncogene and prognostic biomarker. [PDF]

Discov Oncol
Liu L, Li T, He J, Liu G.
europepmc   +1 more source

<i>CDKN2AIPNL</i>: a potential pan-cancer biomarker. [PDF]

Front Genet
Yuan Y, Ma SX, Liu H, Gong Y, Sun X, Wang Q, Zhang W.   +6 more
europepmc   +1 more source

<i>ZNF25</i> as an immunotherapy target: pan-cancer biomarker potential and mechanistic exploration in glioma. [PDF]

Front Oncol
Yi X, Zhang X, Huang L, Chen Y, You M, Jia H, Hou L, Hu C, Huang K, Wang Y.   +9 more
europepmc   +1 more source

Developing a pan cancer therapy based on DISE-inducing short RNAs. [PDF]

Mol Ther Nucleic Acids
Murmann AE, Ebadi M, Patel M, Ewe A, Barajas S, Xiao S, Ko MJ, Lee S, Cai W, Paudel B, Sun L, Bartom ET, Kocherginsky M, Liu Y, Kim DH, Aigner A, Peter ME.   +16 more
europepmc   +1 more source